Dongguan Kanghua Hospital

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure	Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Enrolling by invitation	Phase 2	2026-09-10	NCT07813390
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation	Aneurysm, Brain Death, Coma, Consciousness Disorders, Death, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Unconsciousness, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, intracranial arterial disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 4	2026-03-03	NCT06308952
Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial	Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Calculi, Male Urogenital Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, kidney disorder, nephrolithiasis, urinary system disorder, urolithiasis	Recruiting	Not applicable	2025-03-27	NCT06898216

Clinical trials